The effect of the apolipoprotein E phenotype on cholesteryl ester transfer protein activity, plasma lipids and apolipoprotein A I levels in hypercholesterolaemic patients on colestipol and lovastatin treatment

European Journal of Clinical Pharmacology

Volumn 54, Issue 12, 1999, Pages 903-910

  Korhonen, T ^a   Hannuksela, M L ^a   Seppanen S ^a   Kervinen, K ^a   Kesäniemi, Y Antero ^a   Savolainen, M J ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

Apolipoprotein E; Hypercholesterolaemia; Lipid lowering drugs

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN E; CHOLESTEROL ESTER TRANSFER PROTEIN; COLESTIPOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PHARMACOGENETICS; PHENOTYPE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ANTILIPEMIC AGENTS; APOLIPOPROTEINS E; CARRIER PROTEINS; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEINS; COLESTIPOL; FEMALE; GLYCOPROTEINS; HUMANS; HYPERCHOLESTEROLEMIA; LOVASTATIN; MALE; MIDDLE AGED; PHENOTYPE; TRIGLYCERIDES;

EID: 0033008998     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050573     Document Type: Article

References (49)

1. Mahley RW (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240: 622-630
2. Kuusi T, Nieminen MS, Ehnholm C, Yki-Järvinen H, Valle M, Nikkilä EA, Taskinen MR (1989) Apoprotein E polymorphism and coronary artery disease. Increased prevalence of apolipoprotein E-4 in angiographically verified coronary patients. Arteriosclerosis 9: 237-241
3. Ukkola O, Kervinen K, Salmela PI, von Dickhoff K, Laakso M, Kesäniemi YA (1993) Apolipoprotein E is related to macro-and microangiopathy in non-insulin-dependent diabetes mellitus. Atherosclerosis 101: 9-15
4. Stuyt PM, Brenninkmeijer BJ, Demacker PN, Hendriks JC, van Elteren P, Stalenhoef AF, van 't Laar A (1991) Apolipoprotein E phenotypes, serum lipoproteins and apolipoproteins in angiographically assessed coronary heart disease. Scand J Clin Lab Invest 51: 425-435
5. Berglund L, Wiklund O, Eggertsen G, Olofsson SO, Eriksson M, Linden T, Bondjers G, Angelin B (1993) Apolipoprotein E phenotypes in familial hypercholesterolaemia: importance for expression of disease and response to therapy. J Intern Med 233: 173-178
6. Luc G, Bard JM, Arveiler D, Evans A, Cambou JP, Bingham A, Amouyel P, Schaffer P, Ruidavets JB, Cambien F, Fruchart JC, Ducimetiere P (1994) Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. The ECTIM Study. Arterioscler Thromb 14: 1412-1419
7. Mahley RW, Innerarity TL, Rall SC Jr., Weisgraber KH, Taylor JM (1990) Apolipoprotein E: genetic variants provide insights into its structure and function. Curr Opin Lipidol 1: 87-95
8. Kinoshita M, Arai H, Fukasawa M, Watanabe T, Tsukamoto K, Hashimoto Y, Inoue K, Kurokawa K, Teramoto T (1993) Apolipoprotein E enhances lipid exchange between lipoproteins mediated by cholesteryl ester transfer protein. J Lipid Res 34: 261-268
9. Tall A (1995) Plasma lipid transfer proteins. Ann Rev Biochem 64: 235-257
10. Kesäniemi YA (1996) Genetics and cholesterol metabolism. Curr Opin Lipidol 7: 124-131
11. Sakai N, Yamashita S, Hirano K, Ishigami M, Arai T, Kobayashi K, Funahashi T, Matsuzawa Y (1995) Decreased affinity of low density lipoprotein (LDL) particles for LDL receptors in patients with cholesteryl ester transfer protein deficiency. Eur J Clin Invest 25: 332-339
12. McPherson R, Mann CJ, Tall AR, Hogue M, Martin L, Milne RW, Marcel YL (1991) Plasma concentrations of cholesteryl ester transfer protein in hyperlipoproteinemia. Relation to cholesteryl ester transfer protein activity and other lipoprotein variables. Arterioscler Thromb 11: 797-804
13. Tato F, Vega GL, Tall AR, Grundy SM (1995) Relation between cholesterol ester transfer protein activities and lipoprotein cholesterol in patients with hypercholesterolemia and combined hyperlipidemia. Arterioscler Thromb Vasc Biol 15: 112-120
14. Bruce C, Tall AR (1995) Cholesteryl ester transfer proteins, reverse cholesterol transport, and atherosclerosis. Curr Opin Lipidol 6: 306-311
15. Tato F, Vega GL, Grundy SM (1995) Bimodal distribution of cholesteryl ester transfer protein activities in normotriglyceridemic men with low HDL cholesterol concentrations. Arterioscler Thromb Vase Biol 15: 446-451
16. Gaw A, Packard CJ, Lindsay GM, Murray EF, Griffin BA, Caslake MJ, Colquhoun I, Wheatley DJ, Lorimer AR, Shepherd J (1996) Effects of colestipol alone and in combination with simvastatin on apolipoprotein B metabolism. Arterioscler Thromb Vase Biol 16: 236-249
17. Watts GF, Cummings MH, Umpleby M, Quiney JR, Naoumova R, Thompson GR, Sonksen PH (1995) Simvastatin decreases the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: pathophysiology and therapeutic implications. Eur J Clin Invest 25: 559-567
18. Homma Y, Ozawa H, Kobayashi T, Yamaguchi H, Sakane H, Nakamura H (1995) Effects of simvastatin on plasma lipoprotein subfractions, cholesterol esterification rate, and cholesteryl ester transfer protein in type II hyperlipoproteinemia. Atherosclerosis 114: 223-234
19. Sehayek E, Butbul E, Avner R, Levkovitz H, Eisenberg S (1994) Enhanced cellular metabolism of very low density lipoprotein by simvastatin. A novel mechanism of action of HMG-CoA reductase inhibitors. Eur J Clin Invest 24: 173-178
20. Savolainen MJ, Korhonen T, Aalto-Setälä K, Kontula K, Kesäniemi YA (1991) Screening for a prevalent mutation in patients with severe hypercholesterolaemia. Hum Genet 87: 125-128
21. Savolainen MJ, Hannuksela M, Seppänen S, Kervinen K, Kesäniemi YA (1990) Increased high-density lipoprotein cholesterol concentration in alcoholics is related to low cholesteryl ester transfer protein activity. Eur J Clin Invest 20: 593-599
22. Groener JEM, Pelton RW, Kostner GM (1986) Improved estimation of cholesteryl ester transfer/exchange activity in serum or plasma. Clin Chem 32: 283-286
23. Menzel HJ, Utermann G (1986) Apolipoprotein E phenotyping from serum by Western blotting. Electrophoresis 7: 492-495
24. Inazu A, Brown ML, Hesler CB, Agellon LB, Koizumi J, Takata K, Maruhama Y, Mabuchi H, Tall AR (1990) Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. N Engl J Med 323: 1234-1238
25. Seip RL, Moulin P, Cocke T, Tall A, Kohrt WM, Mankowitz K, Semenkovich CF, Ostlund R, Schonfeld G (1993) Exercise training decreases plasma cholesteryl ester transfer protein. Arterioscler Thromb 13: 1359-1367
26. Foger B, Wohlfarter T, Ritsch A, Lechleitner M, Miller CH, Dienstl A, Patsch JR (1994) Kinetics of lipids, apolipoproteins, and cholesteryl ester transfer protein in plasma after a bicycle marathon. Metabolism 43: 633-639
27. Freeman DJ, Griffin BA, Murray E, Lindsay GM, Gaffney D, Packard CJ, Shepherd J (1993) Smoking and plasma lipoproteins in man: effects on low density lipoprotein cholesterol levels and high density lipoprotein subfraction distribution. Eur J Clin Invest 23: 630-640
28. Dullaart RP, Groener JE, Dikkeschei BD, Erkelens DW, Doorenbos H (1991) Elevated cholesteryl ester transfer protein activity in IDDM men who smoke. Possible factor for unfavorable lipoprotein profile. Diabetes Care 14: 338-341
29. Gupta AK, Ross EA, Myers JN, Kashyap ML (1993) Increased reverse cholesterol transport in athletes. Metabolism 42: 684-690
30. Marcel YL, McPherson R, Hogue M, Czarnecka H, Zawadzki Z, Weech PK, Whitlock ME, Tall AR, Milne RW (1990) Distribution and concentration of cholesteryl ester transfer protein in plasma of normolipemic subjects. J Clin Invest 85: 10-17
31. Hirano K, Yamashita S, Kuga Y, Sakai N, Nozaki S, Kihara S, Arai T, Yanagi K, Takami S, Menju M, Ishigami M, Yoshida Y, Kameda-Takemura K, Hayashi K, Matsuzawa Y (1995) Atherosclerotic disease in marked hyperalphalipoproteinemia. Combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase. Arterioscler Thromb Vasc Biol 15: 1849-1856
32. Atger V, Leclerc T, Cambillau M, Guillemain R, Marti C, Moatti N, Girard A (1993) Elevated high density lipoprotein concentrations in heart transplant recipients are related to impaired plasma cholesteryl ester transfer and hepatic lipase activity. Atherosclerosis 103: 29-41
33. Christison JK, Rye KA, Stocker R (1995) Exchange of oxidized cholesteryl linoleate between LDL and HDL mediated by cholesteryl ester transfer protein. J Lipid Res 36: 2017-2026
34. Ohta T, Nakamura R, Takata K, Saito Y, Yamashita S, Horiuchi S, Matsuda I (1995) Structural and functional differences of subspecies of ApoA-I containing lipoprotein in patients with plasma cholesteryl ester transfer deficiency. J Lipid Res 35: 696-704
35. Kleinveld HA, Demacker PN, De Haan AF, Stalenhoef AF (1993) Decreased in vitro oxidizability of low-density lipoprotein in hypercholesterolaemic patients treated with 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors. Eur J Clin Invest 23: 289-295
36. Guerin M, Dolphin PJ, Talussot C, Gardette J, Berthezene F, Chapman MJ (1995) Pravastatin modulates cholesteryl ester transfer from HDL to apoB-containing lipoproteins and lipoprotein subspecies profile in familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 15: 1359-1368
37. Forte TM, Goth-Goldstein R, Nordhausen RW, McCall MR (1993) Apolipoprotein A-I-cell membrane interaction: extracellular assembly of heterogenous nascent HDL particles. J Lipid Res 34: 317-324
38. von Eckardstein A, Castro G, Wybranska I, Theret N, Duchateau P, Duverger N, Fruchart JC, Ailhaud G, Assmann G (1993) Interaction of reconstituted high density lipoprotein discs containing human apolipoprotein A-I (Apo A-I) variants with murine adipocytes and macrophages. J Biol Chem 268: 2616-2622
39. Ehnholm C, Lukka M, Kuusi T, Nikkilä E, Utermann G (1986) Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations. J Lipid Res 27: 227-235
40. Mänttäri M, Koskinen P, Ehnholm C, Huttunen JK, Manninen V (1991) Apolipoprotein E polymorphism influences the serum cholesterol response to dietary intervention. Metabolism 40: 217-221
41. O'Malley JP, Illingworth DR (1990) The influence of apolipoprotein E phenotype on the response to lovastatin therapy in patients with heterozygous familial hypercholesterolemia. Metabolism 39: 150-154
42. Ojala JP, Helve E, Ehnholm C, Aalto-Setälä K, Kontula KK, Tikkanen MJ (1991) Effect of apolipoprotein E polymorphism and XbaI polymorphism of apolipoprotein B on response to lovastatin treatment in familial and non-familial hypercholesterolaemia. J Intern Med 230: 397-405
43. Carmena R, Roederer G, Mailloux H, Lussier-Cacan S, Davignon J (1993) The response to lovastatin treatment in patients with heterozygous familial hypercholesterolemia is modulated by apolipoprotein E polymorphism. Metabolism 42: 895-901
44. Boerwinkle E, Brown SA, Rohrbach K, Gotto AM Jr., Patsch W (1991) Role of apolipoprotein E and B gene variation in determining response of lipid, lipoprotein, and apolipoprotein levels to increased dietary cholesterol. Am J Hum Genet 49: 1145-1154
45. Martin LJ, Connelly PW, Nancoo D, Wood N, Zhang ZJ, Maguire G, Quinet E, Tall AR, Marcel YL, McPherson R (1993) Cholesteryl ester transfer protein and high density lipoprotein responses to cholesterol feeding in men: relationship to apolipoprotein E genotype. J Lipid Res 34: 437-446
46. Lehtimäki T, Moilanen T, Porkka K, Åkerblom HK, Rönnemaa T, Räsänen L, Viikari J, Ehnholm C, Nikkari T (1995) Association between serum lipids and apolipoprotein E phenotype is influenced by diet in a population-based sample of free-living children and young adults: the Cardiovascular Risk in Young Finns Study. J Lipid Res 36: 653-661
47. Kuzuya M, Kuzuya F (1993) Probucol as an antioxidant and antiatherogenic drug. Free Radic Biol Med 14: 67-77
48. Lavy A, Brook GJ, Dankner G, Ben Amotz A, Aviram M (1991) Enhanced in vitro oxidation of plasma lipoproteins derived from hypercholesterolemic patients. Metabolism 40: 794-799
49. Savolainen MJ, Rantala M, Kervinen K, Järvi L, Suvanto K, Rantala T, Kesäniemi YA (1991) Magnitude of dietary effects on plasma cholesterol concentration: role of sex and apolipoprotein E phenotype. Atherosclerosis 86: 145-152